Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults.
Z J Pan, … , C J Anderson, H A Stafford
Z J Pan, … , C J Anderson, H A Stafford
Published July 1, 1998
Citation Information: J Clin Invest. 1998;102(1):215-222. https://doi.org/10.1172/JCI1969.
View: Text | PDF
Research Article

Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults.

  • Text
  • PDF
Abstract

A subset of SLE patients has serologically detectable autoantibodies to the ribosomal P proteins (anti-P). We reported the discovery of covert anti-P antibodies and their masking IgG-inhibitory antibodies in the sera of healthy adults. The aim of this study was to determine if these IgG-inhibitory antibodies are anti-idiotypic antibodies (anti-Ids). IgG and IgG-depleted fractions of plasma from two healthy adults were assayed for inhibition of anti-P F(ab')2 binding to the ribosomal P proteins in immunoblot. Anti-P antibody activity was completely inhibited by plasma IgG, whereas there was no inhibition by IgG-depleted plasma. IgG-inhibitory antibodies recognized a cross-reactive epitope among anti-P from different SLE patients. Plasma IgG from one healthy adult was depleted of pepsin agglutinators and generic anti-F(ab')2 antibodies by adsorption with an affinity column prepared with normal IgG F(ab')2. Unretained IgG bound exclusively to anti-P F(ab')2 in ELISA. Using four affinity columns, we isolated IgG anti-Ids to anti-P antibodies from four healthy adults. These purified anti-Ids bound to anti-P F(ab')2 from a healthy adult and SLE patients. They did not bind to F(ab')2 fragments prepared from normal IgG or anti-dsDNA. Ribosomal antigens blocked this anti-Id-Id interaction. Purified anti-Ids inhibited the binding of anti-P F(ab')2 from patients to ribosomal P proteins. SLE patients without overt anti-P antibodies also possessed IgG anti-Ids to anti-P antibodies. We conclude that IgG-inhibitory antibodies are anti-Ids to anti-P antibodies, and are directed to public idiotopes on anti-P antibodies. These anti-Ids may be part of an Id network that regulates anti-P antibody expression, and perhaps pathogenicity.

Authors

Z J Pan, C J Anderson, H A Stafford

×

Total citations by year

Year: 2020 2016 2014 2012 2011 2010 2009 2008 2007 2006 2005 2003 2002 2001 2000 1999 Total
Citations: 2 2 1 4 1 1 5 1 2 1 2 2 1 2 1 1 29
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (29)

Title and authors Publication Year
Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases
SY Pan, YC Chia, HR Yee, AY Cheng, CE Anjum, Y Kenisi, MK Chan, MB Wong
Future Science OA 2020
Immunogenic properties of immunoglobulin superfamily members within complex biological networks
J Odales, JG Valle, F Martínez-Cortés, K Manoutcharian
Cellular Immunology 2020
Autoantibodies in SLE: Specificities, Isotypes and Receptors
B Dema, N Charles
Antibodies 2016
Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro
S Kivity, Y Shoenfeld, MT Arango, DJ Cahill, SL OKane, M Zusev, I Slutsky, M Harel-Meir, J Chapman, T Matthias, M Blank
Rheumatology 2016
Anti-ribosomal-P antibodies in lupus nephritis, neuropsychiatric lupus, lupus hepatitis, and Chagas’ disease: promising yet limited in clinical utility
M Abraham, CT Derk
Rheumatology International 2014
Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse
X Wang, A Zhang, Y Liu, S Chen, Z Feng, W Shang, M Maziarz, J Radtke, CS Hampe
PloS one 2012
Protective role of anti-idiotypic antibodies in autoimmunity – Lessons for type 1 diabetes
CS Hampe
Autoimmunity 2012
Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse
X Wang, A Zhang, Y Liu, S Chen, Z Feng, W Shang, M Maziarz, J Radtke, CS Hampe, IR Cohen
PloS one 2012
Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis
G Berencsi
2012
Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis
H Tadema, CG Kallenberg, CA Stegeman, P Heeringa
PloS one 2011
The immunogenicity of humanized and fully human antibodies: Residual immunogenicity resides in the CDR regions
FA Harding, MM Stickler, J Razo, R DuBridge
mAbs 2010
Autoimmunity: increasing suspects in the CD4+ T cell lineup
MT Palmer, CT Weaver
Nature Immunology 2009
Antiphospholipid antibodies: paradigm in transition
LL Horstman, W Jy, CJ Bidot, YS Ahn, RE Kelley, R Zivadinov, AH Maghzi, M Etemadifar, SA Mousavi, A Minagar
Journal of Neuroinflammation 2009
Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies
S Oak, J Radtke, M Landin-Olsson, C Törn, A Lernmark, CS Hampe
Journal of Immunological Methods 2009
Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay
Y Muro, K Sugiura, Y Morita, Y Tomita
Scandinavian Journal of Rheumatology 2009
Naturally occurring auto-antibodies in homeostasis and disease
HU Lutz, CJ Binder, S Kaveri
Trends in Immunology 2009
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes
S Oak, LK Gilliam, M Landin-Olsson, C Törn, I Kockum, CR Pennington, MJ Rowley, MR Christie, JP Banga, CS Hampe
Proceedings of the National Academy of Sciences 2008
Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis
S Matus, PV Burgos, M Bravo-Zehnder, R Kraft, OH Porras, P Farías, LF Barros, F Torrealba, L Massardo, S Jacobelli, A González
Journal of Experimental Medicine 2007
The therapeutic potential of targeting anti-Ribosomal-P antibody in treating SLE patients with depression
M Blank, I Beinglass, Y Shoenfeld
Expert Opinion on Biological Therapy 2007
The Autoimmune Diseases
I Kang, J Craft
The Autoimmune Diseases 2006
Production and characterization of a human monoclonal anti-idiotype to anti-ribosomal P antibodies
W Zhang, M Reichlin
Clinical Immunology 2005
BLyS antagonists and peptide tolerance induction
JT Merrill
Lupus 2005
Autoantibody-mediated Inhibition of Pancreatic Cancer Cell Growth in an Athymic (Nude) Mouse Model
J Gardner-Thorpe, H Ito, SW Ashley, EE Whang
Pancreas 2003
Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission
D Cavill, SA Waterman, TP Gordon
Arthritis & Rheumatism 2003
Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies
A Kenderov, V Minkova, D Mihailova, N Giltiay, S Kyurkchiev, I Kehayov, M Kazatchkine, S Kaveri, A Pashov
Clinical & Experimental Immunology 2002
Possible role of antiidiotypes in the loss of anti-topoisomerase I antibodies: Comment on the article by Kuwana et al
HA Stafford, ZJ Pan, CJ Anderson
Arthritis & Rheumatism 2001
A Murine Monoclonal Anti-idiotype to Anti-ribosomal P Antibodies: Production, Characterization, and Use in Systemic Lupus Erythematosus
ZJ Pan, CJ Anderson, HA Stafford
Clinical Immunology 2001
The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN-gamma) production by murine splenocytes
M Soto, C Alonso, JM Requena
Clinical & Experimental Immunology 2000
Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects
Q Chen, MJ Rowley, IR Mackay
Hepatology 1999

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts